Key DatesFebruary 13, 2012
Abstract submission opens
March 12, 2012
Preliminary program available online
April 16, 2012
Abstract submission closes
June 1, 2012
Registration and accommodation opens
June 15, 2012
Late breaking and featured clinical trials submission opens
July 15, 2012
Late breaking and featured clinical trials submission deadline
August 3, 2012
Early bird registration closes
September 24, 2012
Online registration closes
In 2007, Pfizer and Bristol-Myers Squibb entered into a global alliance combining Bristol-Myers Squibb’s long-standing strengths in cardiovascular drug development and commercialization with Pfizer’s global scale expertise in this field.
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit http://www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.
Pfizer Canada Inc. is the Canadian operation of Pfizer Inc, one of the world’s leading biopharmaceutical companies. Pfizer discovers, develops, manufactures and markets prescription medicines for humans and animals. At Pfizer, we’re working together for a healthier world. For more information, visit www.pfizer.ca.